Expression of concern
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
Paper Information
Record ID:
52502
Author(s):
Journal:
Publication Date:
February 04, 2008
Retraction Date:
February 28, 2024
(1.7 year years ago)
Subjects:
Institutions:
- Department of Cellular and Molecular Biology and Pathology, University of Naples Federico II, Naples, Italy
- Istituto di Endocrinologia ed Oncologia Sperimentale, CNR, IEOS, Naples, Italy
- Department of Molecular Virology, Immunology and Medical Genetics, Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
- Facolta` di Scienze Biotecnologiche, University of Naples Federico II, Naples, Italy
Countries:
Article Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1038/s41388-024-02989-3Citations (296)
296
Total Citations5
Post-Retraction(1.7%)
288
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
497
Days since retraction (latest)
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
Margherita Iaboni, Valentina Russo, Raffaela Fontanella et al. (11 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Jan 2016
71 citations
71 citations
2980 days before retraction
Role of microRNAs in inflammation-associated liver cancer
Lin Huan, Liang Linhui, Xianghuo He
Cancer Biology and Medicine
Open Access
Published: Jan 2016
22 citations
22 citations
2980 days before retraction
Effect of miRNAs in lung cancer suppression and oncogenesis
Suning Zhang, Zongang Liu
Open Life Sciences
Open Access
Published: Jan 2016
5 citations
5 citations
2980 days before retraction
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
Saswati N. Chand, Kevin O’Hayer, Fernando F. Blanco et al. (5 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2016
104 citations
104 citations
2980 days before retraction
Micrornas as Pharmacogenomic Biomarkers for Drug Efficacy and Drug Safety Assessment
Igor Koturbash, William H. Tolleson, Lei Guo et al. (8 authors)
Biomarkers in Medicine
Open Access
Published: Oct 2015
76 citations
76 citations
3047 days before retraction
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
Giuseppina Roscigno, Cristina Quintavalle, Elvira Donnarumma et al. (16 authors)
Oncotarget
Open Access
Published: Oct 2015
89 citations
89 citations
3054 days before retraction
MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling
Jingjing Qu, Min Li, Jian An et al. (9 authors)
International Journal of Oncology
Open Access
Published: Sep 2015
82 citations
82 citations
3075 days before retraction
MicroRNAs as regulators of apoptosis mechanisms in cancer
Valentina Pileczki, Roxana Cojocneanu, Mahafarin Maralani et al. (5 authors)
Medicine and Pharmacy Reports
Open Access
Published: Sep 2015
79 citations
79 citations
3075 days before retraction
Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway
Hai Jin, Fan Qiao, Yan Wang et al. (5 authors)
Oncology Reports
Open Access
Published: Sep 2015
193 citations
193 citations
3095 days before retraction
Death Ligands and Granulysin: Mechanisms of Tumor Cell Death Induction and Therapeutic Opportunities
Luis Martínez‐Lostao, Diego de Miguel, Sameer Al-Wasaby et al. (5 authors)
Immunotherapy
Published: Aug 2015
24 citations
24 citations
3133 days before retraction
MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway
Tianjun Chen, Fei Gao, Sifang Feng et al. (5 authors)
Biochemical and Biophysical Research Communications
Published: Jul 2015
23 citations
23 citations
3155 days before retraction
Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
Ryoichi Tanaka, Mitsuhiro Tomosugi, Mano Horinaka et al. (5 authors)
PLoS ONE
Open Access
Published: May 2015
49 citations
49 citations
3218 days before retraction
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging
Mattia Boeri, Stefano Sestini, Orazio Fortunato et al. (7 authors)
Expert Review of Molecular Diagnostics
Published: Apr 2015
35 citations
35 citations
3226 days before retraction
Gene Profiling Characteristics of Radioadaptive Response in AG01522 Normal Human Fibroblasts
Jue Hou, Fan Wang, Peizhong Kong et al. (6 authors)
PLoS ONE
Open Access
Published: Apr 2015
26 citations
26 citations
3239 days before retraction
Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment
Samira Goldar, Mahmoud Shekari Khaniani, Sima Mansoori Derakhshan et al. (4 authors)
Asian Pacific Journal of Cancer Prevention
Open Access
Published: Apr 2015
557 citations
557 citations
3253 days before retraction
MicroRNA and MET in lung cancer.
Matteo Brighenti
PubMed
Published: Apr 2015
31 citations
31 citations
3255 days before retraction
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
Qinhong Xu, Pei Li, Xin Chen et al. (14 authors)
Oncotarget
Open Access
Published: Mar 2015
80 citations
80 citations
3258 days before retraction
MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2
Fan Yang, Wei Wang, Chunhui Zhou et al. (10 authors)
Tumor Biology
Published: Mar 2015
84 citations
84 citations
3285 days before retraction
Can the chemotherapeutic agents perform anticancer activity though miRNA expression regulation? Proposing a new hypothesis
Chiranjib Chakraborty, C. George Priya Doss, Renu Sarin et al. (5 authors)
PROTOPLASMA
Published: Feb 2015
8 citations
8 citations
3296 days before retraction
Growth inhibitory effects of miR‐221 and miR‐222 in non‐small cell lung cancer cells
Ryo Yamashita, Mitsuo Sato, Tomohiko Kakumu et al. (9 authors)
Cancer Medicine
Open Access
Published: Jan 2015
69 citations
69 citations
3316 days before retraction
Caracterização da expressão de microRNAs em carcinoma de mama receptores hormonais positivos e HER-2 negativo
Daniele Carvalho Calvano Mendes
Unknown Journal
Open Access
Published: Jan 2015
3319 days before retraction
Role of Exosomal Noncoding RNAs in Lung Carcinogenesis
Tao Sun, Bill Kalionis, Guoying Lv et al. (5 authors)
BioMed Research International
Open Access
Published: Jan 2015
43 citations
43 citations
3345 days before retraction
MicroRNAs in Prostate Cancer: Small RNAs with Big Roles
Ping Mu
Journal of Clinical & Cellular Immunology
Open Access
Published: Jan 2015
2 citations
2 citations
3345 days before retraction
microRNA and Lung Cancer
Valerio Del Vescovo, Michela A. Denti
Advances in experimental medicine and biology
Open Access
Published: Jan 2015
86 citations
86 citations
3345 days before retraction
Paper citing MicroRNA signatures of TRAIL resistance in human n...
Unknown Authors
Unknown Journal
Published: Jan 2015
3345 days before retraction
The emerging role of microRNAs in resistance to lung cancer treatments
Lauren MacDonagh, Steven G. Gray, Stephen P. Finn et al. (6 authors)
Cancer Treatment Reviews
Published: Dec 2014
90 citations
90 citations
3354 days before retraction
The role of cFLIP in breast cancer stem cells
Rhiannon French
Unknown Journal
Published: Dec 2014
3372 days before retraction
Non-coding RNAs in lung cancer
Biagio Ricciuti, Carmen Mecca, Lucio Crinò et al. (6 authors)
Oncoscience
Open Access
Published: Nov 2014
36 citations
36 citations
3392 days before retraction
Antisense therapeutics in oncology: current status
Ammad Ahmad Farooqı, Zia Marwat, Jordi Muntané
OncoTargets and Therapy
Open Access
Published: Nov 2014
52 citations
52 citations
3406 days before retraction
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
Christian Rolfo, Daniele Fanale, David S. Hong et al. (12 authors)
Current Pharmaceutical Biotechnology
Open Access
Published: Aug 2014
54 citations
54 citations
3468 days before retraction
Targeting death receptors for TRAIL by agents designed by Mother Nature
Sahdeo Prasad, Ji Hye Kim, Subash C. Gupta et al. (4 authors)
Trends in Pharmacological Sciences
Published: Aug 2014
59 citations
59 citations
3485 days before retraction
Caracterização da expressão de microRNAS em carcinoma de mama triplo negativo
Carlos Marino Cabral Calvano Filho
Unknown Journal
Open Access
Published: Jul 2014
3508 days before retraction
Paper citing MicroRNA signatures of TRAIL resistance in human n...
Unknown Authors
Unknown Journal
Published: Jun 2014
3535 days before retraction
The role of microRNA in castration-resistant prostate cancer
William Thieu, Derya Tilki, Ralph W. deVere White et al. (4 authors)
Urologic Oncology Seminars and Original Investigations
Open Access
Published: Jun 2014
40 citations
40 citations
3544 days before retraction
MicroRNA-222 promotes the proliferation and migration of cervical cancer cells
Yi Sun, Bo Zhang, Jiajing Cheng et al. (8 authors)
Clinical and investigative medicine
Open Access
Published: Jun 2014
25 citations
25 citations
3559 days before retraction
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen, Dong-Yu Gao, Leaf Huang
Advanced Drug Delivery Reviews
Open Access
Published: May 2014
599 citations
599 citations
3569 days before retraction
The role of miRNAs in Cancer: From Pathogenesis to Therapeutic Implications
Mehmet Seven, Ömer Faruk Karataş, Mehmet Buğrahan Düz et al. (4 authors)
Future Oncology
Published: May 2014
68 citations
68 citations
3590 days before retraction
Prognostic Significance of microRNA-221/222 Expression in Cancers: Evidence from 1,204 Subjects
Wang Jin, Sha Liu, Guo Ping Sun et al. (8 authors)
The International Journal of Biological Markers
Published: Apr 2014
10 citations
10 citations
3620 days before retraction
Paper citing MicroRNA signatures of TRAIL resistance in human n...
Unknown Authors
Unknown Journal
Published: Apr 2014
3620 days before retraction
A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy
Nan Bi, Jianzhong Cao, Yongmei Song et al. (12 authors)
PLoS ONE
Open Access
Published: Mar 2014
44 citations
44 citations
3635 days before retraction
Deregulation of microRNA expression in thyroid tumors
Ziming Yuan, Zhili Yang, Qi Zheng
Journal of Zhejiang University SCIENCE B
Open Access
Published: Mar 2014
19 citations
19 citations
3651 days before retraction
Expression Patterns of MicroRNAs in Porcine Endometrium and Their Potential Roles in Embryo Implantation and Placentation
Lijie Su, Ruize Liu, Wei Cheng et al. (7 authors)
PLoS ONE
Open Access
Published: Feb 2014
82 citations
82 citations
3675 days before retraction
MicroRNAs and anticancer drugs
Zhiwei Xing, Dongsheng Li, Ling Yang et al. (5 authors)
Acta Biochimica et Biophysica Sinica
Published: Feb 2014
18 citations
18 citations
3676 days before retraction
MicroRNA-Modulated Apoptotic and Autophagic Signaling Networks in Cancer
Bo Liu, Yuquan Wei
Springer eBooks
Published: Jan 2014
3710 days before retraction
Therapeutic Use of MicroRNAs in Lung Cancer
Orazio Fortunato, Mattia Boeri, Carla Verri et al. (5 authors)
BioMed Research International
Open Access
Published: Jan 2014
54 citations
54 citations
3710 days before retraction
MicroRNA in lung cancer
Pooja Joshi, Justin Middleton, Young-Jun Jeon et al. (4 authors)
World Journal of Methodology
Open Access
Published: Jan 2014
59 citations
59 citations
3710 days before retraction
The Impact of Extracellular Vesicle-Encapsulated Circulating MicroRNAs in Lung Cancer Research
Yu Fujita, Kazuyoshi Kuwano, Takahiro Ochiya et al. (4 authors)
BioMed Research International
Open Access
Published: Jan 2014
63 citations
63 citations
3710 days before retraction
MicroRNAs-Role in Lung Cancer
Małgorzata Guz, Adolfo Rivero‐Müller, Estera Okoń et al. (7 authors)
Disease Markers
Open Access
Published: Jan 2014
71 citations
71 citations
3710 days before retraction
MicroRNA-222 Expression and Its Prognostic Potential in Non-Small Cell Lung Cancer
Kaiping Mao, Weina Zhang, Xiaomin Liang et al. (4 authors)
The Scientific World JOURNAL
Open Access
Published: Jan 2014
18 citations
18 citations
3710 days before retraction
The Role of MicroRNA in Lung Cancer Drug Resistance and Targeted Therapy
Zhaohui Gong, Zhuo Dong, Lihua Yang et al. (9 authors)
Springer eBooks
Published: Jan 2014
2 citations
2 citations
3710 days before retraction
Quick Stats
Total Citations:
296
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025